Cargando…

Is there a difference in FDG PET findings of invasive ductal carcinoma of the breast with and without coexisting DCIS?

OBJECTIVE(S): Studies have reported that invasive ductal carcinoma (IDC) with coexisting ductal carcinoma in situ (DCIS) show lower metastatic potential and recurrence and better overall survival than pure IDC. In this study, we assessed F-18 fluorodeoxyglucose (FDG) positron emission tomography/com...

Descripción completa

Detalles Bibliográficos
Autores principales: Sarikaya, Ismet, Sarikaya, Ali, Albatineh, Ahmed N., Tastekin, Ebru, Sezer, Yavuz Atakan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mashhad University of Medical Sciences 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6994776/
https://www.ncbi.nlm.nih.gov/pubmed/32064280
http://dx.doi.org/10.22038/aojnmb.2019.41658.1284
_version_ 1783493258937106432
author Sarikaya, Ismet
Sarikaya, Ali
Albatineh, Ahmed N.
Tastekin, Ebru
Sezer, Yavuz Atakan
author_facet Sarikaya, Ismet
Sarikaya, Ali
Albatineh, Ahmed N.
Tastekin, Ebru
Sezer, Yavuz Atakan
author_sort Sarikaya, Ismet
collection PubMed
description OBJECTIVE(S): Studies have reported that invasive ductal carcinoma (IDC) with coexisting ductal carcinoma in situ (DCIS) show lower metastatic potential and recurrence and better overall survival than pure IDC. In this study, we assessed F-18 fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) images of patients with newly diagnosed IDC to determine if there is any difference in PET findings in IDC-DCIS and pure IDC cases. METHODS: FDG PET/CT images of patients with newly diagnosed IDC of the breast who subsequently underwent breast surgery and had histopathology result in our records were further evaluated. Tumor grade, pathological staging, and presence of DCIS were noted from the histopathology results. Standardized uptake value (SUV) of the primary tumor (SUV(max) and SUL(max)), other hypermetabolic foci in the breast, and ipsilateral normal breast were measured. Presence of axillary and distant metastases was noted. RESULTS: Fifty seven (57) patients with IDC were included. Coexisting DCIS was present in 44 (IDC-DCIS) and not present in 13 (pure IDC) cases. Per histopathology, the primary tumor was unifocal in 33 IDC-DCIS (75%) and 12 pure IDC (92.3%) cases, and multifocal in 11 IDC-DCIS cases (25%), and 1 pure IDC case (7.7%). FDG uptake was multifocal in 20 IDC-DCIS cases (45.5%) and 1 pure IDC case (7.7%), and unifocal in 24 IDC-DCIS (54.5%), and 12 pure IDC (92.3%) cases. There was no significant difference in patient age, size of the primary tumor, SUV(max) and SUL(max) of the primary tumor and SUV(max) of the normal breast in IDC-DCIS and pure IDC cases (p>0.05). Pathology showed axillary metastasis in all 13 pure IDC (100%), and 27 IDC-DCIS (61.4%) cases. PET showed axillary uptake in 25 IDC-DCIS (56.8%), and 8 pure IDC (61.5%) cases, and abnormal/questionable distant uptake in 12 IDC-DCIS cases and 1 pure IDC case. CONCLUSION: In our preliminary findings, multifocal breast FDG uptake and multifocal tumor appear to be more common in IDC-DCIS than pure IDC. There is no significant difference in SUV and size of the primary tumor in IDC-DCIS and pure IDC cases. Axillary metastases appear to be more common in pure IDC than IDC-DCIS cases.
format Online
Article
Text
id pubmed-6994776
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Mashhad University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-69947762020-02-14 Is there a difference in FDG PET findings of invasive ductal carcinoma of the breast with and without coexisting DCIS? Sarikaya, Ismet Sarikaya, Ali Albatineh, Ahmed N. Tastekin, Ebru Sezer, Yavuz Atakan Asia Ocean J Nucl Med Biol Original Article OBJECTIVE(S): Studies have reported that invasive ductal carcinoma (IDC) with coexisting ductal carcinoma in situ (DCIS) show lower metastatic potential and recurrence and better overall survival than pure IDC. In this study, we assessed F-18 fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) images of patients with newly diagnosed IDC to determine if there is any difference in PET findings in IDC-DCIS and pure IDC cases. METHODS: FDG PET/CT images of patients with newly diagnosed IDC of the breast who subsequently underwent breast surgery and had histopathology result in our records were further evaluated. Tumor grade, pathological staging, and presence of DCIS were noted from the histopathology results. Standardized uptake value (SUV) of the primary tumor (SUV(max) and SUL(max)), other hypermetabolic foci in the breast, and ipsilateral normal breast were measured. Presence of axillary and distant metastases was noted. RESULTS: Fifty seven (57) patients with IDC were included. Coexisting DCIS was present in 44 (IDC-DCIS) and not present in 13 (pure IDC) cases. Per histopathology, the primary tumor was unifocal in 33 IDC-DCIS (75%) and 12 pure IDC (92.3%) cases, and multifocal in 11 IDC-DCIS cases (25%), and 1 pure IDC case (7.7%). FDG uptake was multifocal in 20 IDC-DCIS cases (45.5%) and 1 pure IDC case (7.7%), and unifocal in 24 IDC-DCIS (54.5%), and 12 pure IDC (92.3%) cases. There was no significant difference in patient age, size of the primary tumor, SUV(max) and SUL(max) of the primary tumor and SUV(max) of the normal breast in IDC-DCIS and pure IDC cases (p>0.05). Pathology showed axillary metastasis in all 13 pure IDC (100%), and 27 IDC-DCIS (61.4%) cases. PET showed axillary uptake in 25 IDC-DCIS (56.8%), and 8 pure IDC (61.5%) cases, and abnormal/questionable distant uptake in 12 IDC-DCIS cases and 1 pure IDC case. CONCLUSION: In our preliminary findings, multifocal breast FDG uptake and multifocal tumor appear to be more common in IDC-DCIS than pure IDC. There is no significant difference in SUV and size of the primary tumor in IDC-DCIS and pure IDC cases. Axillary metastases appear to be more common in pure IDC than IDC-DCIS cases. Mashhad University of Medical Sciences 2020 /pmc/articles/PMC6994776/ /pubmed/32064280 http://dx.doi.org/10.22038/aojnmb.2019.41658.1284 Text en © 2020 mums.ac.ir All rights reserved This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Sarikaya, Ismet
Sarikaya, Ali
Albatineh, Ahmed N.
Tastekin, Ebru
Sezer, Yavuz Atakan
Is there a difference in FDG PET findings of invasive ductal carcinoma of the breast with and without coexisting DCIS?
title Is there a difference in FDG PET findings of invasive ductal carcinoma of the breast with and without coexisting DCIS?
title_full Is there a difference in FDG PET findings of invasive ductal carcinoma of the breast with and without coexisting DCIS?
title_fullStr Is there a difference in FDG PET findings of invasive ductal carcinoma of the breast with and without coexisting DCIS?
title_full_unstemmed Is there a difference in FDG PET findings of invasive ductal carcinoma of the breast with and without coexisting DCIS?
title_short Is there a difference in FDG PET findings of invasive ductal carcinoma of the breast with and without coexisting DCIS?
title_sort is there a difference in fdg pet findings of invasive ductal carcinoma of the breast with and without coexisting dcis?
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6994776/
https://www.ncbi.nlm.nih.gov/pubmed/32064280
http://dx.doi.org/10.22038/aojnmb.2019.41658.1284
work_keys_str_mv AT sarikayaismet isthereadifferenceinfdgpetfindingsofinvasiveductalcarcinomaofthebreastwithandwithoutcoexistingdcis
AT sarikayaali isthereadifferenceinfdgpetfindingsofinvasiveductalcarcinomaofthebreastwithandwithoutcoexistingdcis
AT albatinehahmedn isthereadifferenceinfdgpetfindingsofinvasiveductalcarcinomaofthebreastwithandwithoutcoexistingdcis
AT tastekinebru isthereadifferenceinfdgpetfindingsofinvasiveductalcarcinomaofthebreastwithandwithoutcoexistingdcis
AT sezeryavuzatakan isthereadifferenceinfdgpetfindingsofinvasiveductalcarcinomaofthebreastwithandwithoutcoexistingdcis